Work

Predicting Outcomes in Patients With Chronic Myeloid Leukemia at Any Time During Tyrosine Kinase Inhibitor Therapy

Year: 2014

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2014.01.003

Authors: Alfonso Quintás-Cardama, Sangbum Choi, Hagop Kantarjian, Elias Jabbour, Xuelin Huang, Jorge Cortes

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, Novartis, Ariad Pharmaceuticals, National Institutes of Health, National Cancer Institute

Awards: G1066808569, G111615301, G1901027039, G2169464185, The Therapy of CML, G2873061488, G446918063, Cancer Center Support Grant

OpenAlex ID: W2100540289

FWCI: 1.223

Cites: 19

Cited by: 16

Related to: 10